Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

8,437 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,769
Recruiting: 1,010
Ph III recruiting: 99
Growth YoY: −1.7%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 35.6%
Trials / 1,000 deaths: 75 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,348)

clinicaltrialsPublishedShowing 351–355 of 355 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00460447	Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation	unknown	Phase 1 / Phase 2	30	University Hospital Carl Gustav CarusOTHER	1	Apr 16, 2007	clinicaltrials
NCT00157274	Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome	unknown	Phase 2	20	Latin American Cooperative Onco-Haematology Group - PeruOTHER	1	Apr 3, 2007	clinicaltrials